Response to PD1 inhibition in conventional chondrosarcoma

Response to PD1 inhibition in conventional chondrosarcoma

Abstract Background Chondrosarcoma is one of the most common malignant bone tumors in adults. Conventional chondrosarcoma represents around 85% of all chondrosarcomas and is notoriously difficult to treat with chemotherapy. Case presentation We describe a 67-year-old man with metastatic conventional...

Full description

Bibliographic Details
Main Authors: Michael J. Wagner, Robert W. Ricciotti, Jose Mantilla, Elizabeth T. Loggers, Seth M. Pollack, Lee D. Cranmer
Format: Article
Language:English
Published: BMJ Publishing Group 2018-09-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Chondrosarcoma
Immunotherapy
Sarcoma
Bone cancer
Online Access:http://link.springer.com/article/10.1186/s40425-018-0413-z

Internet

http://link.springer.com/article/10.1186/s40425-018-0413-z

Similar Items